Delivery Order SPE2DB20D3103-SPE2DB24FM2L0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,457.92 firm fixed-price delivery order is for the supply of Methotrexate 2.5 mg tablets and is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical worth up to $999,999,999.00. This IDC serves as the primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Methotrexate 2.5 mg tablets. The contract, valued at $2,294.28, is a firm-fixed-price delivery order with an ultimate completion date of August 9, 2024. Amerisourcebergen, through its corporate office division, will provide these pharmaceutical products to support federal healthcare programs and military treatment facilities. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,685.34 Firm Fixed Price delivery order is for the supply of Methotrexate 2.5 mg tablets. The contract has an ultimate completion date of May 28, 2024 and was awarded on May 24, 2024. This appears to be a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4,565,470,746 Methotrexate 2.5 mg tablets in 100-count bottles. The contract has a ceiling value of $2,867.85 and is a Firm Fixed Price Delivery Order with an ultimate completion date of August 16, 2024. The contract was awarded on August 15, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award, with ID SPE2DB20D3505|SPE2DB23FU3G5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $2,261.36 fixed-price delivery order is for the supply of 4,561,358,523 units of Methotrexate 2.5 mg tablets in 100-count packages. The contract has a performance period ending on June 28, 2023. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $18,880 delivery order by the Defense Logistics Agency to provide 50 mg/2 ml vials of methotrexate. The firm fixed price order is for performance from August 24-25, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No set aside designation or subcontractors are indicated. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,846.48 Firm Fixed Price Delivery Order is for the supply of 4,565,116,351 methylergonovine 0.2 mg tablets. The contract has an ultimate completion date of July 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and other federal healthcare programs....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,588.56 firm fixed-price delivery order is for the supply of Methotrexate 2.5 mg tablets, a medication used to treat various conditions. The award is not designated as a set-aside contract. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $127,530 delivery order by the Defense Logistics Agency to provide 100 tablets of 2.5 mg methotrexate. The order is to be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania under firm fixed pricing by August 10, 2023. No set-aside designation or subcontracting details were provided. The Defense Logistics Agency routinely issues such orders under various prime vendor and...
- This federal contract award, valued at $2,512.71, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Methotrexate 2.5 mg tablets (100s) and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., also known as Amerisourcebergen. The company holds a significant Indefinite Delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM2L0Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,870.00 firm fixed-price contract is for the delivery of 4,563,298,552 units of the drug Methotrexate 1 GM vials. The award has an ultimate completion date of January 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated with a set-aside requirement, indicating open competition. The contract award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems, across a wide spectrum of medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 1/10/24 |